Kymera Therapeutics (KYMR) operating margin

Operating margin · fiscal 2025
-881.2%

Kymera Therapeutics (KYMR) had an operating margin of -881.2% in fiscal 2025 (the year ended December 31, 2025). That is 335.9 percentage points lower than the -545.4% of fiscal 2024. Figures as of 17 Nov 2026, 22:24 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Operating margin, fiscal 2025
-881.2%
Change on fiscal 2024
−335.9 pts
Highest on record
-136.1%fiscal 2020
Lowest on record
-1438.5%fiscal 2019
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Kymera Therapeutics operating margin, in more detail

Across the 7 fiscal years on record (2019–2025), the highest was -136.1% in fiscal 2020 and the lowest -1438.5% in fiscal 2019. The fiscal 2025 figure is higher than in 17% of the 6 earlier fiscal years on record, whose median is -277.5%.

Net margin was -794.0% in fiscal 2025.

History · 7 fiscal years

Operating margin by fiscal year

  • Operating margin
  • Net margin

Kymera Therapeutics operating margin, year by year

Kymera Therapeutics (KYMR) operating margin by fiscal year
Fiscal yearOperating marginChangeYear endedNet margin
2025-881.2% 335.9 pts down-794.0%
2024-545.4% 334.7 pts down-475.6%
2023-210.6% 133.8 pts up-187.0%
2022-344.4% 206.3 pts down-330.6%
2021-138.0% 2.0 pts down-137.6%
2020-136.1% 1302.4 pts up-134.0%
2019-1438.5%—-1405.8%

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

Operating margin at health care companies of similar size

Operating margin of Kymera Therapeutics and comparable companies
CompanyOperating marginFiscal year
Fresenius Medical Care FMS9.3%2025
Kymera Therapeutics KYMR-881.2%2025
DaVita DVA14.7%2025
Halozyme Therapeutics HALO57.5%2025
Universal Health Services UHS11.5%2025
Repligen RGEN5.6%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on KYMR

Kymera Therapeutics, figure by figure

Kymera Therapeutics (KYMR) overview: price, valuation and scorecardAll health care companies by market value

Kymera Therapeutics operating margin: questions and answers

What is Kymera Therapeutics's operating margin?

Kymera Therapeutics (KYMR) had an operating margin of -881.2% in fiscal 2025 (the year ended December 31, 2025). That is 335.9 percentage points lower than the -545.4% of fiscal 2024.

Is Kymera Therapeutics's operating margin high or low compared with its own history?

The fiscal 2025 figure is higher than in 17% of the 6 earlier fiscal years on record, whose median is -277.5%.

What are the highest and lowest operating margin figures on record for Kymera Therapeutics?

Across the 7 fiscal years on record (2019–2025), the highest was -136.1% in fiscal 2020 and the lowest -1438.5% in fiscal 2019.

What are Kymera Therapeutics's gross and net margins?

Net margin was -794.0% in fiscal 2025.

How is Kymera Therapeutics's operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Kymera Therapeutics (KYMR) operating margin”, data as of 17 November 2026. https://funkfolio.com/stock/KYMR/operating-margin

Underlying data: the company's filings with the SEC and Yahoo Finance.